Endoscopic and clinical features of gastric ulcers in Japanese patients with or without Helicobacter pylori infection who were using NSAIDs or low-dose aspirin

[1]  C. Hawkey,et al.  Predictors of gastroduodenal erosions in patients taking low‐dose aspirin , 2010, Alimentary pharmacology & therapeutics.

[2]  Koji Takeuchi,et al.  Gastric mucosal defense and cytoprotection: bench to bedside. , 2008, Gastroenterology.

[3]  Y. Sugisaki,et al.  Helicobacter pylori infection‐negative gastric cancer in Japanese hospital patients: Incidence and pathological characteristics , 2007, Cancer science.

[4]  Á. Lanas,et al.  Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations , 2006, Gut.

[5]  K. Haruma,et al.  Endoscopic characteristics and Helicobacter pylori infection in NSAID‐associated gastric ulcer , 2006, Journal of gastroenterology and hepatology.

[6]  C. Hawkey,et al.  Prevalence and incidence of gastroduodenal ulcers during treatment with vascular protective doses of aspirin , 2005, Alimentary pharmacology & therapeutics.

[7]  W. Qureshi.  VIDEO CAPSULE ENDOSCOPY TO PROSPECTIVELY ASSESS SMALL BOWEL INJURY WITH CELECOXIB, NAPROXEN PLUS OMEPRAZOLE, AND PLACEBO , 2005 .

[8]  T. Chiba,et al.  Upper gastrointestinal disorders induced by non-steroidal anti-inflammatory drugs , 2005, Inflammopharmacology.

[9]  K. Fujimori,et al.  A clinical study of Japanese patients with ulcer induced by low‐dose aspirin and other non‐steroidal anti‐inflammatory drugs , 2005, Alimentary pharmacology & therapeutics.

[10]  B. Thjódleifsson,et al.  A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy. , 2005, Gastroenterology.

[11]  K. Sugano,et al.  Recurrent Peptic Ulcers in Patients Following Successful Helicobacter pylori Eradication: A Multicenter Study of 4940 Patients , 2004, Helicobacter.

[12]  T. Fujioka,et al.  Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients , 2003, Journal of Gastroenterology.

[13]  R. Hunt,et al.  Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis , 2002, The Lancet.

[14]  S. Hernández-Díaz,et al.  Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. , 2001, British journal of clinical pharmacology.

[15]  M. Fujishima,et al.  Clinical and endoscopic features of nonsteroidal anti-inflammatory drug-induced colonic ulcerations , 2001, American Journal of Gastroenterology.

[16]  S. Hernández-Díaz,et al.  Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.

[17]  M. Asaka,et al.  Non‐Helicobacter pylori and non‐NSAID peptic ulcer disease in the Japanese population , 2000, European journal of gastroenterology & hepatology.

[18]  M. Minami,et al.  Helicobacter pylori-negative gastric and duodenal ulcers , 1999, Journal of Gastroenterology.

[19]  C. Arvanitakis,et al.  An endoscopic study of gastroduodenal lesions induced by nonsteroidal anti-inflammatory drugs. , 1999, Clinical therapeutics.

[20]  A. Barkun,et al.  Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs. Omeprazole versus Misoprostol for NSAID-induced Ulcer Management (OMNIUM) Study Group. , 1999, The New England journal of medicine.

[21]  N. Goldstein,et al.  The histopathology of nonsteroidal anti-inflammatory drug-associated colitis. , 1998, American journal of clinical pathology.

[22]  G. Singh,et al.  Recent considerations in nonsteroidal anti-inflammatory drug gastropathy. , 1998, The American journal of medicine.

[23]  A. Barkun,et al.  Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs , 1998 .

[24]  J. Stachura,et al.  Infection of Helicobacter pylori in gastric adaptation to continued administration of aspirin in humans. , 1998, Gastroenterology.

[25]  T. Chiba,et al.  Intragastric distribution of nonsteroidal anti-inflammatory drug-related ulcers in patients without collagen diseases. , 1997, Journal of clinical gastroenterology.

[26]  F. Chan,et al.  Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers , 1997, The Lancet.

[27]  B E Dunn,et al.  Helicobacter pylori , 1997, Clinical microbiology reviews.

[28]  F. Mégraud,et al.  Epidemiology of Helicobacter pylori infection with special reference to professional risk. , 1997, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[29]  T. Chiba,et al.  Distribution of prostaglandin E receptors in the rat gastrointestinal tract. , 1997, Prostaglandins.

[30]  T. Chiba,et al.  Cellular localization of mRNAs for prostaglandin E receptor subtypes in mouse gastrointestinal tract. , 1997, The American journal of physiology.

[31]  D. Graham,et al.  Ulcer site and complications: relation to Helicobacter pylori infection and NSAID use. , 1996, Endoscopy.

[32]  A. Macpherson,et al.  Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. , 1993, Gastroenterology.

[33]  D. Graham,et al.  Long-term nonsteroidal antiinflammatory drug use and Helicobacter pylori infection. , 1991, Gastroenterology.

[34]  B. Vernon‐roberts,et al.  The effects of some anti-arthritic drugs and cytokines on the shape and function of rodent macrophages. , 1991, International journal of experimental pathology.

[35]  Kenji Takahashi,et al.  The Significance of Low Serum Pepsinogen Levels to Detect Stomach Cancer Associated with Extensive Chronic Gastritis in Japanese Subjects , 1989, Japanese journal of cancer research : Gann.

[36]  T. Takemoto,et al.  An Endoscopic Recognition of the Atrophic Border and its Significance in Chronic Gastritis , 1969 .

[37]  H. Lindner,et al.  Fortschritte der Laparoskopie , 1969 .

[38]  西野 眞史.  Relationship between low-dose aspirin-induced gastric mucosal injury and intragastric pH in healthy volunteers , 2011 .

[39]  K. Chayama,et al.  Eradication of Helicobacter pylori increases the incidence of hyperlipidaemia and obesity in peptic ulcer patients. , 2005, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[40]  D. Graham,et al.  Visible small-intestinal mucosal injury in chronic NSAID users. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[41]  A. Battler,et al.  Endoscopy in Asymptomatic Minidose Aspirin Consumers , 2005, Digestive Diseases and Sciences.

[42]  L. Trümper.  From bench to bedside , 2005, Medizinische Klinik.

[43]  D. Forman,et al.  Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. , 2004, The Cochrane database of systematic reviews.

[44]  K. Narushima,et al.  Non-Helicobacter pylori ulcer disease in rheumatoid arthritis patients receiving long-term NSAID therapy. , 2000, Journal of gastroenterology.

[45]  M. Kasuga,et al.  Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress? , 2000, Journal of gastroenterology.

[46]  P. Konturek.  Physiological, immunohistochemical and molecular aspects of gastric adaptation to stress, aspirin and to H. pylori-derived gastrotoxins. , 1997, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[47]  G. Elta,et al.  Long-term follow-up of Helicobacter pylori treatment in non-ulcer dyspepsia patients. , 1995, The American journal of gastroenterology.

[48]  T. Shimoyama,et al.  Combination Therapies with a Proton Pump Inhibitor for Helicobacter pylori‐Infected Gastric Ulcer Patients , 1995, Journal of clinical gastroenterology.